
TY  - JOUR
TI  - Abstracts (Continue in Part I)
JO  - Proceedings of the International Society for Magnetic Resonance in Medicine
JA  - Proc. Soc. Magn. Reson. Med.
VL  - 1988
IS  - S3
SN  - 1065-9889
UR  - https://doi.org/10.1002/mrmp.22419880302
DO  - doi:10.1002/mrmp.22419880302
SP  - 1
EP  - 50
PY  - 1988
ER  - 

TY  - JOUR
TI  - Abstract Presentations from the AABB Annual Meeting Boston, MA, October 13–16, 2018
JO  - Transfusion
JA  - Transfusion
VL  - 58
IS  - S2
SN  - 0041-1132
UR  - https://doi.org/10.1111/trf.14903
DO  - doi:10.1111/trf.14903
SP  - 6A
EP  - 254A
PY  - 2018
ER  - 

TY  - JOUR
TI  - Wednesday, 27 July 2011
JO  - Journal of Thrombosis and Haemostasis
VL  - 9
IS  - s2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2011.04380_3.x
DO  - doi:10.1111/j.1538-7836.2011.04380_3.x
SP  - 499
EP  - 711
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Session 2
JO  - European Journal of Neurology
VL  - 13
IS  - s2
SN  - 1351-5101
UR  - https://doi.org/10.1111/j.1468-1331.2006.01622.x
DO  - doi:10.1111/j.1468-1331.2006.01622.x
SP  - 169
EP  - 294
PY  - 2006
ER  - 

TY  - JOUR
TI  - Abstracts and Index of Authors
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 17
IS  - 5
SN  - 0277-0008
UR  - https://doi.org/10.1002/j.1875-9114.1997.tb03809.x
DO  - doi:10.1002/j.1875-9114.1997.tb03809.x
SP  - 1079
EP  - 1133
PY  - 1997
ER  - 

AU  - Westman, E. L.
AU  - Matewish, J. M.
AU  - Lam, J. S.
C7  - pp. 443-468
TI  - Pseudomonas
SN  - 9780813812373
UR  - https://doi.org/10.1002/9780470958209.ch23
DO  - doi:10.1002/9780470958209.ch23
SP  - 443-468
KW  - Pseudomonas
KW  - Pseudomonas species - remarkable nutritional diversity
KW  - Pseudomonas aeruginosa - opportunistic pathogen
KW  - division of pathogenesis of P. aeruginosa infections - bacterial colonization, multiplication, systemic disease
KW  - host immune defense mechanisms - exerting bactericidal effects
KW  - Pilus-deficient strains - causing epithelial cell damage
PY  - 1997
AB  - Summary This chapter contains sections titled: Introduction Overview of Pathogenesis Virulence Factors of Pseudomonas aeruginosa Antibiotic Resistance Impact of Whole Genome Sequences Vaccines Conclusions and Future Prospects References
ER  - 

TY  - JOUR
TI  - Society for Pediatric Dermatology 42nd Annual Meeting Poster Presentations July 14–17, 2016|Minneapolis, Minnesota
JO  - Pediatric Dermatology
JA  - Pediatr Dermatol
VL  - 33
IS  - 6
SN  - 9780813812373
UR  - https://doi.org/10.1111/pde.13062
DO  - doi:10.1111/pde.13062
SP  - 690
EP  - 721
PY  - 2016
ER  - 

TY  - JOUR
TI  - Abstracts from the Third Chinese Congress on Gerontology and Health Industry
JO  - Journal of the American Geriatrics Society
JA  - J Am Geriatr Soc
VL  - 62
IS  - s2
SN  - 9780813812373
UR  - https://doi.org/10.1111/jgs.13075
DO  - doi:10.1111/jgs.13075
SP  - S335
EP  - S395
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster abstracts
JO  - Neuropathology and Applied Neurobiology
JA  - Neuropathol Appl Neurobiol
VL  - 40
IS  - s1
SN  - 9780813812373
UR  - https://doi.org/10.1111/nan.12121
DO  - doi:10.1111/nan.12121
SP  - 33
EP  - 59
PY  - 2014
ER  - 

TY  - JOUR
AU  - Holst, Otto
AU  - Ulmer, Artur J.
AU  - Brade, Helmut
AU  - Flad, Hans-Dieter
AU  - Rietschel, Ernst Th.
TI  - Biochemistry and cell biology of bacterial endotoxins
JO  - FEMS Immunology & Medical Microbiology
VL  - 16
IS  - 2
SN  - 9780813812373
UR  - https://doi.org/10.1111/j.1574-695X.1996.tb00126.x
DO  - doi:10.1111/j.1574-695X.1996.tb00126.x
SP  - 83
EP  - 104
KW  - Gram-negative bacteria
KW  - Endotoxin
KW  - Lipopolysaccharide
KW  - Lipopolysaccharide structure
KW  - Bioactivity of lipopolysaccharide
PY  - 1996
ER  - 

TY  - JOUR
TI  - Scientific Section
JO  - Transfusion
VL  - 45
IS  - s3
SN  - 9780813812373
UR  - https://doi.org/10.1111/j.1537-2995.2005.00629_1.x
DO  - doi:10.1111/j.1537-2995.2005.00629_1.x
SP  - 1A
EP  - 151A
PY  - 2005
ER  - 

TY  - JOUR
TI  - Scientific Section
JO  - Transfusion
VL  - 48
IS  - s2
SN  - 9780813812373
UR  - https://doi.org/10.1111/j.1537-2995.2008.01891.x
DO  - doi:10.1111/j.1537-2995.2008.01891.x
SP  - 1A
EP  - 241A
PY  - 2008
ER  - 

TY  - JOUR
TI  - Tuesday, December 4, 2007 Subcortical Control of Cortical Excitability 11:00 a.m.-12:30 p.m.
JO  - Epilepsia
VL  - 48
IS  - s6
SN  - 9780813812373
UR  - https://doi.org/10.1111/j.1528-1167.2007.01252_14.x
DO  - doi:10.1111/j.1528-1167.2007.01252_14.x
SP  - 410
EP  - 410
PY  - 2007
AB  - Robert S. Fisher 1 , Lucy Brown 2 and Karen Gale 3 ( 1 Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA ; 2 Albert Einstein College of Medicine, Yeshiva University, Bronx, NY and 3 Neurology and Neuroscience, Georgetown University School of Medicine, Washington, D.C., WA ) Summary: This symposium will evaluate the role of certain subcortical circuits in seizures and cortical excitability. Data show that thalamocortical, basal ganglia, midbrain and hindbrain circuits play important roles in seizure generation, conduction and modulation. The session will provide a basic overview of these systems and circuits, both functionally and anatomically. The thalamus uses systems able to synchronize or desynchronize electrical activity in wide regions of cortex. These thalamocortical systems play a role in generation of absence seizures and propagation of secondarily generalized seizures. The basal ganglia have a close relationship with the cortex, and may ?gate? activity through a widespread corticostriate system, thus potentially both enhancing and suppressing seizure activity. Midbrain and hindbrain circuits have been shown to have profound effects on seizures. The session will discuss how an understanding of subcortical-cortical networks can lead to therapeutic advances, with use of electrical brain stimulation or targeted pharmacotherapy as examples.
ER  - 

TY  - JOUR
TI  - Monday, December 3, 2007 Strategic Approaches to Pediatric Epilepsy Surgery 7:00 p.m.-9:00 p.m.
JO  - Epilepsia
VL  - 48
IS  - s6
SN  - 9780813812373
UR  - https://doi.org/10.1111/j.1528-1167.2007.01252_12.x
DO  - doi:10.1111/j.1528-1167.2007.01252_12.x
SP  - 410
EP  - 410
PY  - 2007
AB  - Elaine Wyllie 1 and Michael Duchowny 2 ( 1 Cleveland Clinic Foundation, Cleveland, OH and 2 Brain Institute, Miami Children's Hospital, Miami, FL ) Summary: Epilepsy surgery is accepted as an appropriate intervention for children with medically refractory epilepsy. Key elements for surgical candidacy include a localized epileptogenic zone and a low risk for new postoperative neurological deficits. The strategies for identifying these elements for surgical candidacy are in evolution. This Symposium will examine current worldwide variations in pediatric epilepsy surgical practice, based on an international multicenter survey. Faculty will also examine age-related aspects to selection for surgery including lesion timing and type and functional plasticity, and strategies for surgery when MRI is normal or shows multiple lesions. Pediatric neurology and neurosurgery speakers will emphasize the tactics involved in designing a safe and effective plan for surgery for selected infants and children with intractable epilepsy.
ER  - 

TY  - JOUR
TI  - Tuesday, December 4, 2007 Temporal Lobe Epilepsy: Discrete Focus or Spectrum Disorder? 9:00 a.m.-10:30 a.m.
JO  - Epilepsia
VL  - 48
IS  - s6
SN  - 9780813812373
UR  - https://doi.org/10.1111/j.1528-1167.2007.01252_13.x
DO  - doi:10.1111/j.1528-1167.2007.01252_13.x
SP  - 410
EP  - 410
PY  - 2007
AB  - Edward H. Bertram 1 , Gary Mathern 2 , Helen Cross 3 and Maria Thom 4 ( 1 Department of Neurology, University of Virginia, Charlottesville, VA ; 2 Department of Neurosurgery, UCLA, Los Angeles, CA ; 3 Institute of Child Health, University College London, London, United Kingdom and 4 Institute of Neurology, University College London, London, United Kingdom ) Summary: Mesial temporal lobe epilepsy (MTLE) has been synonymous with hippocampal sclerosis, such that the consensus is that the removal of the latter cures the former. There is increasing information, including recent epidemiological data regarding the long term outcomes of surgery, that suggests that the underlying basis for the disorder is more extensive than originally thought. The ultimate question for improving outcomes is ?What is the true focus for MTLE?? Although our understanding of what constitutes the focus remains limited, there is evidence from surgical outcome, pathology, imaging and animal studies that the hippocampus alone is not the answer. Outcome studies show that only a small percentage of patients who are seizure free following surgery for MTLE can successfully stop medications and remain seizure free. Further there is evidence that the number of patients in remission falls steadily, even after a period of seizure freedom. These observations suggest that the seizure focus has not been completely removed. Studies of the temporal lobe pathology demonstrate changes that are variable but which extend beyond the hippocampus. Imaging has been a key factor in identifying structural abnormalities, but we may be missing key pieces of information that could identify the focus more precisely. Animal studies indicate that the ictal onset zone may be extensive and extend well beyond the hippocampus, but a true understanding of the physical substrate for seizure initiation still eludes us. This session is asking questions for which we only have partial answers. What do we know now about the seizure focus in MTLE? What do we need to know to have better outcomes? We don't have any good answers for either question other than a) not enough and b) a lot more. We hope this session will stimulate the participants to fill in the many gaps that now exist.
ER  - 

TY  - JOUR
TI  - Abstracts of the 2012 PNS/Inflammatory Neuropathy Consortium Meeting June 24–27, 2012 Rotterdam, The Netherlands
JO  - Journal of the Peripheral Nervous System
VL  - 17
IS  - 2
SN  - 9780813812373
UR  - https://doi.org/10.1111/j.1529-8027.2012.00410.x
DO  - doi:10.1111/j.1529-8027.2012.00410.x
SP  - 229
EP  - 282
PY  - 2012
ER  - 

TY  - JOUR
TI  - Monday, December 3, 2007 Found in Translation – New Target for Therapies 9:00 a.m.-11:30 a.m.
JO  - Epilepsia
VL  - 48
IS  - s6
SN  - 9780813812373
UR  - https://doi.org/10.1111/j.1528-1167.2007.01252_11.x
DO  - doi:10.1111/j.1528-1167.2007.01252_11.x
SP  - 409
EP  - 409
PY  - 2007
AB  - John W. Swann 1 ( 1 Pediatrics/Neuroscience, Baylor College of Medicine, Houston, TX ) Summary: Epilepsy research scientists and clinicians are collaborating in translating scientific discoveries into new therapies for the intractable epilepsies. Discoveries of clinical researchers are guiding the development of relevant animal models. Studies in these models are leading to the identification of what appear to be key molecular steps in the genesis of epilepsy. These molecular mechanisms provide new targets for the development of rationale therapies, which can be tested in these same models. As an example of the progress being made, this program will review the most recent studies of the consequences of prolonged febrile seizures in children. Potential targets for new therapies that have been discovered in models of febrile seizures, head injury, neonatal seizures and kindling will be discussed.
ER  - 

TY  - JOUR
TI  - Translational Science 2013 Abstracts
JO  - Clinical and Translational Science
JA  - CLINICAL AND TRANSLATIONAL SCIENCE
VL  - 6
IS  - 2
SN  - 9780813812373
UR  - https://doi.org/10.1111/cts.12047
DO  - doi:10.1111/cts.12047
SP  - 103
EP  - 164
PY  - 2013
ER  - 

TY  - JOUR
TI  - 23rd IEC Proceedings
JO  - Epilepsia
VL  - 40
IS  - s2
SN  - 9780813812373
UR  - https://doi.org/10.1111/j.1528-1157.1999.tb01725.x
DO  - doi:10.1111/j.1528-1157.1999.tb01725.x
SP  - 3
EP  - 302
PY  - 1999
ER  - 

TY  - JOUR
TI  - Poster Session 3 Cell and Molecular Biology
JO  - Obesity
VL  - 17
IS  - S2
SN  - 9780813812373
UR  - https://doi.org/10.1038/oby.2009.286
DO  - doi:10.1038/oby.2009.286
SP  - S243
EP  - S315
PY  - 2009
ER  - 
